DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Ondansetron Hydrochloride Preservative Free is a drug marketed by Accord Hlthcare, Am Regent, Apotex Inc, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms Ltd, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira, Luitpold, Mylan Labs Ltd, Sandoz Inc, Sun Pharm Inds Ltd, Taro Pharms Ireland, Teva, West-ward Pharms Int, and Wockhardt. and is included in twenty NDAs.
The generic ingredient in ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the ondansetron hydrochloride profile page.
A generic version of ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE was approved as ondansetron hydrochloride by TEVA on November 22nd, 2006.
Recent Clinical Trials for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Identify potential brand extensions & 505(b)(2) entrants
|University of Pennsylvania||Phase 3|
|Pontificia Universidade Catolica de Sao Paulo||Phase 4|
|Charles University, Czech Republic||Phase 4|